Who is sponsoring NCT04333238?

NCT04333238 is sponsored by Johns Hopkins University.

What drugs are being tested in NCT04333238?

Interventions in NCT04333238: New progress note template, Standard progress note template.

What condition does NCT04333238 study?

NCT04333238 studies Clinical Documentation.

Is NCT04333238 still recruiting?

NCT04333238 is currently completed. Last updated 17 March 2023.

Last reviewed 2023-03-17 · How we verify

NCT04333238: NOTE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Notation Optimization Through Template Engineering

Completed NA Last updated 17 March 2023

What this trial tests

NA trial testing New progress note template in Clinical Documentation in 36 participants. Completed in 1 December 2018.

Timeline

20 January 2017

Primary endpoint
26 April 2017

1 December 2018

Quick facts

Lead sponsor	Johns Hopkins University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	36
Start date	20 January 2017
Primary completion	26 April 2017
Estimated completion	1 December 2018
Sites	1 location across United States

Drugs / interventions tested

New progress note template
Standard progress note template

Conditions studied

Clinical Documentation — all drugs for Clinical Documentation →

Sponsor

Johns Hopkins University

Who can join

Eligibility, any sex, with Clinical Documentation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized non-blinded controlled trial of a standard note template versus a redesigned note template using a simulated patient encounter and the electronic medical record.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of Outpatient Note Templates on Note Quality: NOTE (Notation Optimization through Template Engineering) Randomized Clinical Trial.
Epstein JA, Cofrancesco J, Beach MC, Bertram A, et al · · 2021 · cited 18× · PMID 32901441 · DOI 10.1007/s11606-020-06188-0

Verify or expand the search:

Other Johns Hopkins University trials

Trials by the same sponsor.

NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04333238 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
Last refreshed: 17 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04333238.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing